ProBioGen AG and Transgene expanded their collaboration by adding an additional license agreement for ProBioGen's AGE1.CR.pIX host cell line.
Public source
Publisher name
Public post
๐ฃ ๐ฃ๐ฟ๐ผ๐๐ถ๐ผ๐๐ฒ๐ป๐ก๐ฒ๐๐: ๐ง๐ฟ๐ฎ๐ป๐๐ด๐ฒ๐ป๐ฒ ๐๐ถ๐ฐ๐ฒ๐ป๐๐ฒ๐ ๐๐๐๐ญ.๐๐ฅ.๐ฝ๐๐ซยฎ ๐ณ๐ผ๐ฟ ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐ ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด ProBioGen and Transgene have brโฆ
Company
ProBioGen AG
Intelligent Biopharmaceutical Solutions
- Industry
- Biotechnology Research
- Location
- Berlin, DE
- Company size
- 201โ500 employees
About ProBioGen AG
ProBioGen is a renowned contract development and manufacturing organization (CDMO) and technology provider. We perform cell line development, robust process development, efficient and reliable GMP manufacturing, and outstanding analytical services for proteins and antibodies as well as viral vectors and vaccines. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. Starting in 1994 as a spin-off from the Charitรฉ, we have more than 30 years of experience and run three manufacturing lines in Berlin. 300 employees contribute to advancing next-generation therapies and global biotech innovation. Watch & learn more: https://www.youtube.com/watch?v=ySbh3bkb6iA
See moreLatest activity
Latest activity from ProBioGen AG
5 signals
Presence & Recognition
ProBioGen AG is hosting a live webinar on CMC strategy on Thursday, September 10, 2026, featuring Xiao-Ping Dai, Ph.D. and Dr. Ellen Hilgenberg.
Products & Services
ProBioGen AG launched its Lenti.RiGHT platform, which is built on stable lentiviral producer cell lines for scalable CAR-T manufacturing.
Presence & Recognition
ProBioGen AG is hosting a meeting with Xiao-Ping Dai, Ph.D. and Dr. Ellen Hilgenberg on September 10 to discuss building stage-appropriate CMC strategy and reducing downstream risk.
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
Transgene
Transgene and ProBioGen AG have broadened the scope of their existing collaboration, expanding the scope of Transgene's license agreement for ProBioGen's AGE1.CR.pIX suspension cell line.
Partnerships
Biocytogen
Biocytogen Pharmaceuticals entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule to support innovative drug development in neuroscience.
Partnerships
BioM Biotech Cluster Development GmbH
BioM Biotech Cluster Development GmbH announced that Plectonic Biotech, based in Hallbergmoos north of Munich, entered into a research collaboration with Hamburg-based Evotec to explore a new generation of T-cell-activating approaches for solid tumors.
Partnerships
Just - Evotec Biologics
Just - Evotec Biologics announced a research collaboration between Evotec SE and Plectonic Biotech to explore a novel immunotherapy approach for solid tumors using Plectonicโs programmable LOGIBODY technology combined with Evotecโs BiTco platform.
Partnerships
Charles River Laboratories